Month: April 2021
Company generates modest operating income despite 21% decline in revenue due to COVID-19;
Management avoided layoffs during pandemic and looks forward to recovery;
YTD Fiscal 2022 Shipments + order backlog at sixteen-year high as schools move toward re-opening.TORRANCE, Calif., April 28, 2021 (GLOBE NEWSWIRE) — Virco Mfg. Corporation (NASDAQ: VIRC) today reported financial results for the fourth quarter and full year ended January 31, 2021, in the following press release to shareholders and customers:
A full year of pandemic-related school closures resulted in lower revenues for the fourth quarter and full year ended January 31, 2021. For the quarter, which includes the seasonally slow months of November, December and January, net sales totaled $18,301,000 compared to $27,148,000 in the prior year, a decline of 33%. Due to...
Baristas White Coffee Record Sales Exceed Pre-Pandemic Levels; Amazon Increases Inventory Allocation to Meet Demand as Covid Restrictions Ease
Written by Customer Service on . Posted in Public Companies.
SEATTLE, WA, April 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Baristas Coffee Company/ (OTC PINK:BCCI) reported that sales of its White Coffee single serve pods compatible with the Keurig 2.0 brewing system have exceeded previous record levels achieved leading up to the COVID-19 Pandemic that began just over a year ago.
Sales dropped during the onset of the Pandemic due to significantly decreased production capabilities, and limited inventory allocation from Amazon due to prioritizing essential items. Production capacity is no longer an issue now that people have returned to work and Amazon has just increased its inventory allocation for Baristas White Coffee to unprecedented levels. This newest production run has been completed and is currently being received and distributed to various Amazon fulfillment centers. http://www.trywhitecoffee.com/
Baristas...
Virbac’s 2020 Annual Financial Report
Written by Customer Service on . Posted in Public Companies.
Virbac’s 2020 Annual Financial Report has been filed on the AMF website. It is also available on the company website, at the following address : CORPORATE.VIRBAC.COMAttachmentCommuniqué AMF – EN
Lixte Biotechnology to Discuss Pipeline of Clinical Investigations for Four Cancer Targets at the Benzinga Global Small Cap Conference Being Held May 13-14
Written by Customer Service on . Posted in Public Companies.
Lixte’s pipeline includes three clinical studies and one pharmacology study of lead drug candidate LB-100EAST SETAUKET, NY, April 28, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, will participate in the virtual Benzinga Global Small Cap Conference being held May 13-14, 2021. Lixte will be presenting on Thursday, May 13, 1:00-1:20 pm Eastern Time. Investors may register and consult the conference agenda by visiting the event website.
John S. Kovach, M.D., Lixte founder and chief executive officer, commented, “Our lead drug candidate, LB-100, is currently being studied in clinical investigations targeting some of the most aggressive cancers. If the improvement of standard treatments for diverse...
TAAT™ Lifestyle & Wellness Ltd. Name Change to TAAT™ Global Alternatives Inc. Has Taken Effect as of 9:30 am EDT on Wednesday, April 28, 2021
Written by Customer Service on . Posted in Public Companies.
LAS VEGAS and VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) — TAAT™ GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “TAAT™”) announces that as of 9:30 am EDT today (Wednesday, April 28, 2021), the Company’s name has officially changed from TAAT™ Lifestyle & Wellness Ltd. (the “Former Name”) to TAAT™ Global Alternatives Inc. (the “Updated Name”), as announced in a press release dated Monday, April 26, 2021.
No change has been made to the Company’s ticker symbol as a result of this name change, and the Company’s common shares will continue to trade under the ticker “TAAT” on the Canadian Securities Exchange. The CUSIP number assigned to the Company’s shares following the name change to the Updated Name is 87320M101 (ISIN: CA87320M1014).
No action is required to be taken...
Manny Pacquiao & The Manny Pacquiao Foundation Sign Endorsement Deal with LTNC Takeover Industries
Written by Customer Service on . Posted in Public Companies.
ATLANTA, April 28, 2021 (GLOBE NEWSWIRE) — Labor SMART, Inc. (LTNC) (the “Company”), announced that its recently acquired subsidiary, Takeover Industries Inc., has officially signed an endorsement deal with Manny Pacquiao and The Manny Pacquiao Foundation.
Boxing champion Manny Pacquiao, is regarded as one of the greatest professional boxers of all-time and is the only boxer in history to win titles in eight different weight classes. In addition to serving as a Senator of the Philippines, Pacquiao is also the founder of The Manny Pacquiao Foundation (MPF), a California based non-profit, fighting for those less fortunate and spreading hope around the world.
Manny Pacquiao said, “To create a partnership with an innovative company like Takeover Industries that is focused on health and athletic performance with NXT LVL Hydrogen Water...
Altair International Corp. Provides Corporate Update
Written by Customer Service on . Posted in Public Companies.
PITTSBURGH, April 28, 2021 (GLOBE NEWSWIRE) — Altair International Corp. (“Altair” or the “Company”) (OTC: ATAO) is pleased to provide the following updates on various events and initiatives.
Tier Change
After a lengthy review process, which began shortly before the New Year, Altair has been ‘upgraded’ to the OTCQB tier on OTCMarkets.com. We believe that this tier change will bring increased visibility to the company, in addition to potentially opening new doors to outside investment. Interested parties are encouraged to view the Company’s corporate profile at https://www.otcmarkets.com/stock/ATAO/profile.
EV Lithium Solutions, Inc. (“EVLS”)
Development and testing continue on our recently acquired battery technology, and said development has made significant advances in the past month. Our current focus has been on perfecting...
Affinor Growers to Use TESLA as Alternative Energy Provider
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI; OTCQB: RSSFF) is pleased to announce it has chosen TESLA as the alternative energy provider for the company’s Abbotsford BC vertical growing operation. The solar PV system will offset electrical consumption, lowering operations costs throughout the year.
Outfitted with Affinor’s patented vertical farming technology, the company’s 15,000 sq ft greenhouse is scheduled for lettuce and strawberry production this summer. A license application to Health Canada for a cannabis micro cultivation operation within a walled off section of the greenhouse is also expected this summer. In addition to lower energy costs, TESLA Power Walls will completely support the water irrigation system and ensure continuous power during...
Savosolar wins tender in China to deliver solar heating system to Guangzhou Power Supply Bureau, Guangdong Power Grid Co., Ltd.
Written by Customer Service on . Posted in Public Companies.
Savosolar Plc Company Announcement, Insider information 28 April 2021 at 3.15 p.m. (CEST)
Savosolar wins tender in China to deliver solar heating system to Guangzhou Power Supply Bureau, Guangdong Power Grid Co., Ltd.
Savosolar Plc is selected as the winning bidder to deliver a solar heating system to Guangzhou Power Supply Bureau, Guangdong Power Grid Co., Ltd. (later Guangzhou Power Supply) in China. The value of the system is approximately EUR 500 thousand. Both parties are aiming to finalize the contract within four weeks’ time. Once the contract is signed, the delivery of the system is expected in the autumn 2021 and to be operational by the end of this year. Savosolar large collectors will be installed on a tracker following the sun and maximizing the clean energy output from limited installation space. Project...
Allogene Therapeutics to Present Data from its Anti-CD19 AlloCAR T™ Therapy Program in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology
Written by Customer Service on . Posted in Public Companies.
Longer Term Data from the ALLO-501 Phase 1 ALPHA Study to be Presented Alongside Initial Data from the Phase 1 ALLO-501A ALPHA2 Study
Separate Presentation to Include Safety and PK/PD Data on ALLO-647 Used in, Allogene’s Proprietary Lymphodepletion Regimen
ALLO-501A, Intended for a Potentially Pivotal Phase 2 Trial, Previously Granted FDA Fast Track Designation for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Allogene to Host Virtual CD19 Forum to Review ASCO Datasets on May 19, 2021 at 2:30 p.m. PT/5:30 p.m. ETSOUTH SAN FRANCISCO, Calif. and PARIS, April 28, 2021 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, in collaboration with its development partner Servier, an independent...
